VERIFY V24 SELF-CONTAINED BIOLOGICAL INDICATOR

K140708 · STERIS Corporation · FRC · Jun 16, 2014 · General Hospital

Device Facts

Record IDK140708
Device NameVERIFY V24 SELF-CONTAINED BIOLOGICAL INDICATOR
ApplicantSTERIS Corporation
Product CodeFRC · General Hospital
Decision DateJun 16, 2014
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 880.2800
Device ClassClass 2

Intended Use

The VERIFY® V24 Self-Contained Biological Indicator is intended for routine monitoring of the following sterilizer cycles: - Lumen, Non Lumen and Flexible Cycles of the V-PRO® Low Temperature Sterilization Systems - Default Cycle of the STERRAD 100S Sterilizer - Default Cycle of the STERRAD 200 Sterilizer - Standard and Advanced Cycles of the STERRAD NX Sterilizer - Express, Standard and Flex Scope Cycles of the STERRAD 100NX Sterilizer

Device Story

Self-contained biological indicator (SCBI) used by healthcare providers to monitor sterilization efficacy in V-PRO and STERRAD low-temperature sterilizers. Device contains Geobacillus stearothermophilus spores; placed inside sterilizer alongside medical devices. Post-cycle, user activates SCBI by rupturing internal growth media ampoule using a dedicated activator. Activated SCBI incubated at 55–60°C for ≥24 hours. Visual readout: orange/non-turbid indicates pass; yellow/turbid indicates sterilization failure. Provides objective verification of sterilization process; ensures medical devices are safe for patient use.

Clinical Evidence

Bench testing only. Performance studies included viable spore population assay, resistance characteristics (D-value, survival/kill time), carrier/packaging evaluation, holding time assessment, and recovery methods. Simulated use testing in STERRAD cycles confirmed successful performance with no growth inhibition observed.

Technological Characteristics

Polypropylene vial containing Geobacillus stearothermophilus (ATCC 7953) spores. Incubation: 55-60°C for ≥24 hours. Storage: 16-25°C, 30-60% RH. Standalone device; manual activation via mechanical activator.

Indications for Use

Indicated for routine monitoring of specific V-PRO and STERRAD low-temperature sterilization cycles in healthcare settings. No specific patient population or contraindications described.

Regulatory Classification

Identification

Biological sterilization process indicator: A device intended for use by a health care provider to accompany products being sterilized through a sterilization procedure and to monitor adequacy of sterilization. The device consists of a known number of microorganisms, of known resistance to the mode of sterilization, in or on a carrier and enclosed in a protective package. Subsequent growth or failure of the microorganisms to grow under suitable conditions indicates the adequacy of sterilization. Physical/chemical sterilization process indicator: A device intended for use by a health care provider to accompany products being sterilized through a sterilization procedure and to monitor one or more parameters of the sterilization process. The adequacy of the sterilization conditions as measured by these parameters is indicated by a visible change in the device.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/15 description: The image shows the logo for STERIS. The logo consists of the word "STERIS" in a large, sans-serif font, with a registered trademark symbol to the right of the word. Below the word is a graphic of several horizontal wavy lines stacked on top of each other. JUN | 6 2014 # 510(k) Summary for VERIFY® V24 Self-Contained Biological Indicator ## Sponsor Facility STERIS Corporation 5960 Heisley Road Mentor, OH 44060 Phone: (216) 354-2600 Fax No: (216) 639-4459 ## Manufacturing Facility STERIS Corporation 9325 Pinecone Mentor, OH 44060 Contact: Bill Brodbeck, Ph.D. Director, Regulatory Affairs Telephone: (440) 392-7690 (440) 357-9198 Fax No: e-mail: William brodbeck@steris.com Submission Date: March 20, 2014 STERIS Corporation ■ 5960 Heisley Road ■ Mentor, OH 44060-1834 USA ■ 440-354-2600 ! 5-1 {1}------------------------------------------------ ### 1. Device Name | Trade Name: | VERIFY® V24 Self-Contained Biological Indicator | |----------------------|---------------------------------------------------------------------------------| | Common/usual Name: | Biological Indicator (BI) | | Classification Name: | Indicator, Biological Sterilization Process<br>(21 CFR 880.2800, FRC), Class II | ### 2. Predicate Device Verify Self-Contained Biological Indicator (SCBI) for Vaporized |VH2O2 Sterilization Processes (K073244) modified under K090514. ### 3. Description of Device The VERIFY V24 Self-Contained Biological Indicator (SCBI) is used by healthcare providers to monitor the V-PRO® Low Temperature Sterilization Systems and the STERRAD® 100S, STERRAD 200, STERRAD NX and STERRAD 100NX (Express, Standard and Flex Scope Cycles) Sterilizers. It is designed to accompany medical devices placed in the sterilizer. The user places the VERIFY V24 Self-Contained Biological Indicator into the V-PRO Low Temperature Sterilization System or STERRAD Sterilizer and performs a sterilization cycle. After cycle completion, the SCBI can either be immediately activated or it can be held at room temperature for a maximum of 72 hours (3 days) prior to activation. The SCBI is activated by sealing the vial and rupturing the medium ampoule using the STERIS VERIFY SCBI HP activator. The activator automatically seals the SCBI vial and releases the growth media. The activated SCBI is incubated at 55 – 60 °C for ≥ 24 hours. The SCBI indicates a pass if the media remains orange and non-turbid. The SCBI indicates a failure of sterilization if the media changes from orange to yellow and/or if the media is turbid. ### 4. Intended Use The VERIFY® V24 Self-Contained Biological Indicator is intended for routine monitoring of the following sterilizer cycles: - Lumen. Non Lumen and Flexible Cycles of the V-PRO® Low Temperature . Sterilization Systems - Default Cycle of the STERRAD 100S Sterilizer . - Default Cycle of the STERRAD 200 Sterilizer . {2}------------------------------------------------ - Standard and Advanced Cycles of the STERRAD NX Sterilizer . - Express, Standard and Flex Scope Cycles of the STERRAD 100NX Sterilizer . ### 5. Description of Safety and Substantial Equivalence The VERIFY V24 Self-Contained Biological Indicator has the identical accessories, viable population, resistance characteristics, culture conditions, primary and secondary packaging, and storage conditions as compared to its predicate device, the Verify Self-Contained Biological Indicator (SCBI) for Vaporized (VH2O2) Sterilization Processes (name changed in K090514). Testing submitted (Table 5-1) focused on qualification of the subject device for its proposed new indications for use in STERRAD Sterilizers as all other characteristics remain identical to the predicate device. ## Table 5-1. Summary of Nonclinical Tests: | Fall Test & | and Result : | | |-------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------|--| | SCBI Half Cycle Performance<br>Evaluation in the STERRAD Sterilizer<br>Cycles | Pass<br>SCBIs were sterile in half-cycle testing. | | | SCBI Growth Inhibition Following<br>Exposure to STERRAD Sterilizer Cycles | Pass<br>There was no growth inhibition and no<br>effect of the sterilization process on the<br>media. | | | SCBI Simulated Use in the STERRAD<br>Sterilizer Cycles | Pass<br>Simulated use performance has been<br>successfully demonstrated. | | All performance studies for the VERIFY V24 Self-Contained Biological Indicator recommended within FDA Guidance for Industry and FDA Staff: Biological Indicator (BI) Premarket Notification [510(k)] Submissions have been previously completed, submitted and cleared under K073244 and K090514. These studies and the results are summarized in the appropriate sections throughout this submission and include, but are not limited to: - Viable Spore Population Assay . - Resistance Characteristics ● - Carrier and Primary Packaging Evaluation . - Holding Time Assessment . - . Recovery Methods - Shelf Life . ### Technological Characteristics 6. Table 5-2 compares technological characteristics and specifications to the predicate device. The proposed biological indicator is identical in composition and has the same performance specifications as the predicate. {3}------------------------------------------------ # STERIS Traditional 510(k) PREMARKET NOTIFICATION VERIFY® V24 Self-Contained Biological Indicator | Feature | Proposed Device<br>VERIFY V24 Self-<br>Contained Biological<br>Indicator, | Predicate Device<br>Verify Self-Contained<br>Biological Indicator<br>(SCBI) for Vaporized<br>VH2O2 Sterilization<br>Processes (K073244)<br>modified under K090514 | Comparison | |---------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Intended Use:<br>Method of<br>Monitoring<br>Sterilization<br>Process Parameters | The VERIFY® V24 Self-<br>Contained Biological<br>Indicator is intended for<br>routine monitoring of the<br>following sterilizers and<br>cycles:<br>• Lumen, Non Lumen<br>and Flexible Cycles of<br>the V-PRO® Low<br>Temperature<br>Sterilization Systems<br>• Default Cycle of the<br>STERRAD 100S<br>Sterilizer<br>• Default Cycle of the<br>STERRAD 200<br>Sterilizer<br>•Standard and Advanced<br>Cycles of the<br>STERRAD NX<br>Sterilizer<br>• Express, Standard and<br>Flex Scope Cycles of<br>the STERRAD 100NX<br>Sterilizer | A standard method for<br>frequent monitoring of the<br>V-PRO 1 Low Temperature<br>Sterilizer cycle | The device has been<br>previously cleared for<br>use with the V-PRO 1<br>(K073244), V-PRO 1<br>Plus (K083097) and<br>V-PRO maX<br>(K102330) Low<br>Temperature<br>Sterilization Systems.<br>The proposed device is<br>intended to add the<br>listed ASP STERRAD<br>Sterilization system<br>cycles to the claims. | | Labeling | • Vial Label<br>• Certificate of<br>Performance<br>• Carton Label<br>• Instructions for Use | • Vial Label<br>• Certificate of<br>Performance<br>• Carton Label<br>• Instructions for Use | Proposed and<br>predicate devices have<br>identical labeling<br>except that the<br>instructions for use of<br>the proposed device<br>include the listed<br>STERRAD Sterilizer<br>cycles. | | Organism: Species<br>& Strain | <i>Geobacillus<br/>stearothermophilus</i> ATCC<br>7953 spores | <i>Geobacillus<br/>stearothermophilus</i> ATCC<br>7953 spores | Same | | Accessories | • VERIFY Incubator<br>(Optional)<br>• VERIFY Activator<br>(Optional)<br>• Throughput Process<br>Indicator | • VERIFY Incubator<br>(Optional)<br>• VERIFY Activator<br>(Optional)<br>• Throughput Process<br>Indicator | Same | | Viable Spore<br>Population | The specification range for viable spore population is identical for the proposed<br>device and predicate | | | | Feature | Proposed Device<br>VERIFY V24 Self-<br>Contained Biological<br>Indicator | Predicate Device<br>Verify Self-Contained<br>Biological Indicator<br>(SCBI) for Vaporized<br>VH2O2 Sterilization<br>Processes (K073244)<br>modified under K090514 | Comparison | | Resistance<br>characteristics | The specification range for D-value, survival time and kill time are identical for the<br>proposed device and predicate. | | | | Culture Conditions | • V24 SCBI Growth<br>Media<br>• Incubation Temp: 55-<br>60°C<br>• Incubation Time: ≥24<br>hours | • V24 SCBI Growth<br>Media<br>• Incubation Temp: 55-<br>60°C<br>• Incubation Time: ≥24<br>hours | Same<br>Please note that the<br>reduced incubation<br>time of 24 hours was<br>cleared under<br>K090514. | | Carrier Materials | Polypropylene Vial | Polypropylene Vial | Same | | Packaging:<br>• Primary Pack<br>• Secondary<br>Pack | • Polypropylene Vial<br>• 50 Indicators Supplied<br>in a Cardboard Box | • Polypropylene Vial<br>• 50 Indicators Supplied<br>in a Cardboard Box | Same | | Storage Conditions | 16 - 25°C,<br>30 - 60% RH | 16 - 25°C,<br>30 - 60% RH | Same | | Shelf-life | The labeled shelf life is identical for the proposed device and predicate. | | | ## Table 5-2. VERIFY V24 Self-Contained Biological Indicator · {4}------------------------------------------------ ## STERIS Traditional 510(k) PREMARKET NOTIFICATION VERIFY® V24 Self-Contained Biological Indicator #### 7. Conclusion The VERIFY V24 Self-Contained Biological Indicator is identical in composition and has the same performance specifications as the predicate, therefore, it is substantially equivalent to the claimed predicate device since it is identical in design and performance characteristics and has been qualified for routine monitoring of the STERRAD 100S default cycle, STERRAD 200 default cycle, STERRAD NX Standard and Advanced cycles and STERRAD 100NX Express, Standard and Flex Scope cycles. {5}------------------------------------------------ ### DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-000 June 16, 2014 STERIS Corporation William Brodbeck. Ph.D Director, Regulatory Affairs 5960 Heisley Road Mentor, Ohio 44060 Re: K140708 Trade/Device Name: VERIFY® V24 Self Contained Biological Indicator Regulation Number: 21 CFR 880.2800 Regulation Name: Indicator, Biological Sterilization Process Regulatory Class: II Product Code: FRC Dated: March 20, 2014 Received: March 21, 2014 Dear Dr. Brodbeck We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to conninered phorte with the provisions of the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). and Costhetic rior (110) that to nevice, subject to the general controls provisions of the Act. The I va may, alorely manns of the Act include requirements for annual registration, listing of general controls provisions of practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {6}------------------------------------------------ ### Page 2 - William Brodbeck, Ph.D Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the clectronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.lda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. > Sincerely vours. Teiashri Puro Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {7}------------------------------------------------ # Indications for Use K140708 510(k) Number (if known): Device Name: ## VERIFY® V24 Self-Contained Biological Indicator Indications For Use: The VERIFY® V24 Self-Contained Biological Indicator is intended for routine monitoring of the following sterilizer cycles: - Lumen, Non Lumen and Flexible Cycles of the V-PRO® Low Temperature . Sterilization Systems - Default Cycle of the STERRAD 100S Sterilizer ● - Default Cycle of the STERRAD 200 Sterilizer . - Standard and Advanced Cycles of the STERRAD NX Sterilizer . - Express, Standard and Flex Scope Cycles of the STERRAD 100NX Sterilizer . Prescription Use (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use X (21 CFR 801 Subpart C) ## (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Sreekanth Gutala -S Digitally signed by Sreekanth Gutala -S DN: c=US, o-U.S. Government, ou=HHS ou=FDA, ou=People, 0,9.2342.19200300.100.1.1=200054049 cn=Sreekanth Gutala -5 Date: 2014.06.16 11:31:27 -04'00'
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...